Literature DB >> 35292759

Nesfatin-1 exerts protective effects on acidosis-stimulated chondrocytes and rats with adjuvant-induced arthritis by inhibiting ASIC1a expression.

Yayun Xu1,2,3, Zhuoyan Zai2,3, Tao Zhang2,3, Longfei Wang2,3, Xuewen Qian2,3, Dandan Xu2,3, Jingjing Tao2,3, Zheng Lu2,3, Zhengyu Zhang2,3, Xiaoqing Peng2,3, Feihu Chen4,5,6.   

Abstract

Nesfatin-1, a newly identified energy-regulating peptide, has been reported to possess antioxidant, anti-inflammatory, and antiapoptotic properties; however, to date, its effect on rheumatoid arthritis (RA) has not been previously explored in detail. We previously showed that activation of acid-sensing ion channel 1a (ASIC1a) by acidosis plays an important role in RA pathogenesis. Therefore, in this study, we evaluated the effects of nesfatin-1 on acidosis-stimulated chondrocyte injury in vitro and in vivo and examined the involvement of ASIC1a and the mechanism underlying the effects of nesfatin-1 on RA. Acid-stimulated articular chondrocytes were used to examine one of the several possible mechanisms underlying RA pathogenesis in vitro. The mRNA expression profile of acid-induced chondrocytes treated or not treated with nesfatin-1 was investigated by RNA sequencing. The effects of nesfatin-1 on oxidative stress, inflammation, and apoptosis in acid-induced chondrocytes were measured. The mechanistic effect of nesfatin-1 on ASIC1a expression and intracellular Ca2+ in acid-stimulated chondrocytes was studied. Rats with adjuvant-induced arthritis (AA) were used for in vivo analysis of RA pathophysiology. Cartilage degradation and ASIC1a expression in chondrocytes were detected in rats with AA after intraarticular nesfatin-1 injection. The in vitro experiments showed that nesfatin-1 decreased acidosis-induced cytotoxicity and elevation of intracellular Ca2+ levels in chondrocytes. Moreover, it attenuated acid-induced oxidative stress, inflammation, and apoptosis in chondrocytes. Nesfatin-1 decreased ASIC1a protein levels in acid-stimulated chondrocytes via the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) and nuclear factor kappa-B (NF-κB) signaling pathways. In vivo analysis showed that nesfatin-1 ameliorated cartilage degradation and decreased ASIC1a expression in the chondrocytes of rats with AA. Collectively, nesfatin-1 suppressed acidosis-induced oxidative stress, inflammation, and apoptosis in acid-stimulated chondrocytes and alleviated arthritis symptoms in rats with AA, and its mechanism may be related to its ability to decrease ASIC1a protein levels via the MAPK/ERK and NF-κB pathways.
© 2022. The Author(s), under exclusive licence to United States and Canadian Academy of Pathology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35292759     DOI: 10.1038/s41374-022-00774-y

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.502


  50 in total

1.  In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.

Authors:  Hamed Rezaei; Saedis Saevarsdottir; Kristina Forslind; Kristina Albertsson; Helena Wallin; Johan Bratt; Sofia Ernestam; Pierre Geborek; Ingemar F Pettersson; Ronald F van Vollenhoven
Journal:  Ann Rheum Dis       Date:  2011-09-19       Impact factor: 19.103

Review 2.  Rheumatoid arthritis.

Authors:  David L Scott; Frederick Wolfe; Tom W J Huizinga
Journal:  Lancet       Date:  2010-09-25       Impact factor: 79.321

3.  Nesfatin-1 protects PC12 cells against high glucose-induced cytotoxicity via inhibiting oxidative stress, autophagy and apoptosis.

Authors:  Simin Nazarnezhad; Majid Rahmati; Asghar Shayannia; Zahra Abbasi; Majid Salehi; Mehdi Khaksari
Journal:  Neurotoxicology       Date:  2019-07-16       Impact factor: 4.294

4.  Identification of nesfatin-1 as a satiety molecule in the hypothalamus.

Authors:  Shinsuke Oh-I; Hiroyuki Shimizu; Tetsurou Satoh; Shuichi Okada; Sachika Adachi; Kinji Inoue; Hiroshi Eguchi; Masanori Yamamoto; Toshihiro Imaki; Koushi Hashimoto; Takafumi Tsuchiya; Tsuyoshi Monden; Kazuhiko Horiguchi; Masanobu Yamada; Masatomo Mori
Journal:  Nature       Date:  2006-10-01       Impact factor: 49.962

5.  Apoptotic chondrocyte death in rheumatoid arthritis.

Authors:  H A Kim; Y W Song
Journal:  Arthritis Rheum       Date:  1999-07

6.  Measurement and prediction of radiological progression in early rheumatoid arthritis.

Authors:  M J Plant; J Saklatvala; A A Borg; P W Jones; P T Dawes
Journal:  J Rheumatol       Date:  1994-10       Impact factor: 4.666

7.  Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: A Synopsis.

Authors:  Allan Gibofsky
Journal:  Am J Manag Care       Date:  2014-05       Impact factor: 2.229

8.  The risk of coronary artery disease in patients with rheumatoid arthritis using Chinese herbal products and conventional medicine in parallel: a population-based cohort study.

Authors:  Han-Hua Yu; Nai-Huan Hsiung; Jen-Huai Chiang; Hsuan-Shu Shen
Journal:  BMC Complement Med Ther       Date:  2020-03-30

Review 9.  Diagnosis and Management of Rheumatoid Arthritis: A Review.

Authors:  Daniel Aletaha; Josef S Smolen
Journal:  JAMA       Date:  2018-10-02       Impact factor: 56.272

View more
  1 in total

1.  The Role of ASIC1a in Inflammatory Immune Diseases: A Potential Therapeutic Target.

Authors:  Yinghong Wang; Xiaojie Hu; Yancai Sun; Yan Huang
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.